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a  b  s  t  r  a  c  t
Bovine  Neonatal  Pancytopenia  (BNP)  is a disease  of  calves  characterised  by haematopoietic  depletion,
mediated  by ingestion  of  alloantibodies  in colostrum.  It has  been  linked  epidemiologically  to  vaccination
of  the  dams  of affected  calves  with  a particular  vaccine  (Pregsure)  containing  a  novel  adjuvant.  Evi-
dence  suggests  that  BNP-alloantibodies  are  directed  against  MHC  I molecules,  induced  by  contaminant
bovine  cellular  material  from  Madin-Darby  Bovine  Kidney  (MDBK)  cells  used  in  the  vaccine’s  produc-
tion.  We  aimed  to investigate  the speciﬁcity  of  BNP-alloantibody  for bovine  MHC  I  alleles,  particularly
those  expressed  by  MDBK  cells,  and  whether  depletion  of  particular  cell types  is  due  to  differential  MHC
I expression  levels.
A  complement-mediated  cytotoxicity  assay  was  used  to assess  functional  serum  alloantibody  titres
in  BNP-dams,  Pregsure-vaccinated  dams  with  healthy  calves,  cows  vaccinated  with  an  alternative  prod-
uct and  unvaccinated  controls.  Alloantibody  speciﬁcity  was  investigated  using  transfected  mouse  lines
expressing  the  individual  MHC  I alleles  identiﬁed  from  MDBK  cells  and  MHC  I-deﬁned  bovine  leukocyte
lines.  All  BNP-dams  and  50%  of  Pregsure-vaccinated  cows  were  shown  to  have MDBK-MHC  I speciﬁc
alloantibodies,  which  cross-reacted  to varying  degrees  with  other  MHC  I genotypes.  MHC  I expression
levels  on  different  blood  cell  types,  assessed  by  ﬂow cytometry,  were found  to correlate  with  levels  of
alloantibody-mediated  damage  in  vitro  and  in  vivo.  Alloantibody-killed  bone  marrow  cells  were  shown
to express  higher  levels  of  MHC  I than  undamaged  cells.
The  results  provide  evidence  that MHC  I-speciﬁc  alloantibodies  play  a  dominant  role  in the patho-
genesis  of  BNP.  Haematopoietic  depletion  was  shown  to be dependent  on the  titre  and  speciﬁcity  of
alloantibody  produced  by individual  cows  and  the  density  of  surface  MHC  I expression  by different  cell
types.  Collectively,  the results  support  the  hypothesis  that  MHC  I molecules  originating  from  MDBK  cells
used  in  vaccine  production,  coupled  with  a powerful  adjuvant,  are  responsible  for  the  generation  of
pathogenic  alloantibodies.
ublis©  2015  The  Authors.  P
. Introduction
Bovine Neonatal Pancytopenia (BNP) is a disease of calves that
merged in Europe from 2007 [1,2] and subsequently in New
ealand [3]. It is characterised by profound depletion of periph-
ral leukocytes and thrombocytes and bone marrow trilineage
Abbreviations: BNP, Bovine neonatal pancytopenia; BVDV, Bovine Viral Diar-
hoea Virus; CDC assay, complement-dependent cytotoxicity assay; MDBK cells,
adin-Darby Bovine Kidney cells; PRA, Panel Reactive Antibody.
∗ Corresponding author. Tel.: +44 0 131 651 9246; fax: +44 0 131 651 9105.
E-mail address: charlotte.bell@roslin.ed.ac.uk (C.R. Bell).
ttp://dx.doi.org/10.1016/j.vaccine.2015.05.069
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).hed  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
hypoplasia, and is mediated by the ingestion of alloantibodies in
colostrum [4–6]. BNP has been linked epidemiologically to vacci-
nation of the dams of affected calves with a particular inactivated
Bovine Viral Diarrhoea Virus (BVDV) vaccine (Pregsure BVD, Pﬁzer
Animal Health) which incorporates a novel adjuvant formulation
[7–9]. However the incidence of clinical BNP has been reported to
be only 0.0016% per dose of vaccine sold [10]. This, together with
variable alloantibody binding of individual sera to lymphocytes
from different donor cows [11], suggests speciﬁcity for a highly
polymorphic antigen.
Alloantibodies in BNP-dams have been shown to recognise
Major Histocompatibility Complex class I (MHC I) molecules
[12–14], leading to the hypothesis that Pregsure contains bovine
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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HC  I originating from the Madin-Darby Bovine Kidney (MDBK)
ells used in production of the vaccine, and that this is responsible
or the generation of alloantibodies in particular cows to which the
roduct is administered. However, the speciﬁcity of these alloanti-
odies for individual MHC  I alleles, or quantitative analysis of their
unctional activity, has not been previously demonstrated. Further-
ore it has been suggested that Pregsure might also boost normal
regnancy-induced alloantibodies against paternally-derived MHC
ntigens [6], which have been detected previously in the sera of
ealthy cows [15,16].
Evidence for the mechanism of cellular destruction initiated by
NP alloantibody is limited. While one study [11] demonstrated
 modest increase in cytophagocytosis following overnight incu-
ation with BNP-sera, cell destruction in vivo is more rapid and
rofound [6] suggesting involvement of complement-mediated
ysis. However, previous attempts at inducing complement-
ediated lysis by binding of BNP-alloantibody have been reported
o be unsuccessful [17]. Complement-dependent cytotoxicity (CDC)
ssays are routinely used in pre-transplant screening of recipients
or MHC  I alloantibody, as this method is considered to give clini-
ally relevant results [18,19] and CDC assays have also been used
n cattle to detect naturally-occurring pregnancy-induced serum
lloantibodies [16,20].
Cellular damage mediated by BNP-alloantibody appears not
nly to be limited to the haematopoietic system but also to show
ariable damage to different haematopoietic lineages [6]. This
peciﬁcity, despite the widespread expression of MHC  I by most
ells, has not yet been explained. However we  and others [6,13]
ave suggested that this may  reﬂect differences in the level of
xpression of MHC  I by different cell types, as haematopoietic cells
f the immune system are known to express high levels of MHC
hile some tissue cells express very low levels and non-nucleated
rythrocytes show no expression [21–23].
This study aimed to use a functional assay to assess BNP-
lloantibody speciﬁcity for bovine MHC  I alleles, in particular those
xpressed by the MDBK cell line. Furthermore, it aimed to investi-
ate whether the speciﬁcity of BNP-pathology for particular cell
ypes is due to the levels of MHC  I expressed by the affected
ells.
. Methods
.1. Cows
Sera were collected from four groups of cows, (1) Pregsure-
accinated cows that had produced a calf with clinical signs of BNP
onﬁrmed by bone marrow histopathology (n = 10) or haematology
n = 1) (BNP-dams), (2) Pregsure-vaccinated cows with no history
f producing a calf with clinical signs of BNP (Pregsure-cows, n = 8),
3) cows vaccinated with an alternative brand of inactivated BVDV
accine (Bovilis BVD, MSD  Animal Health) (Bovilis-cows, n = 7), (4)
VDV-unvaccinated, BVDV-free cows (control cows, n = 8).
.2. Preparation of cells
Whole blood was collected in EDTA and peripheral blood mono-
uclear cells (PBMC) prepared by density gradient centrifugation
nd whole leukocytes by erythrocyte lysis, according to standard
ethods. Thrombocyte-rich plasma was prepared by centrifuga-
ion at 170 g for 10 min. Bovine bone marrow cells were collected
rom transversely sectioned ribs from a freshly euthanized ani-
al  by ﬂushing with media plus 5 mM EDTA using a 7G 100 mm
iopsy needle inserted longitudinally into the articular surface.
ollected ﬂow-through was centrifuged (400g, 10 min), contam-
nating erythrocytes lysed prior to washing, and cells stored at (2015) 3488–3496 3489
−180 ◦C in foetal calf serum (FCS) containing 10% DMSO until
use.
2.3. Production of MHC I deﬁned transformed bovine leukocyte
cell lines
Bovine PBMC were transformed by infection with the protozoan
parasites Theileria parva or Theileria annulata, according to pub-
lished methods [24], to establish continuously dividing cell lines
which could be maintained indeﬁnitely in culture [25]. Lines were
generated from four cross-bred BNP-dams, and twelve Holstein
animals expressing previously deﬁned MHC  I haplotypes [26] (Fig.
S1), conﬁrmed by both allele-speciﬁc PCR [27] and sequencing.
2.4. Complement-dependent cytotoxicity assay
A semi-automated complement-dependent cytotoxicity (CDC)
assay was established, allowing quantiﬁcation of live and dead
cells following addition of test sera [15]. Cells were stained with
25 g/ml Hoechst 33342 (Invitrogen) (30 min) and incubated with
serial dilutions of sera (30 min) followed by the addition of rab-
bit complement-HLA-ABC (Invitrogen) (1 h) (all RT, protected from
light). The vital nucleic acid stain Sytox Orange, which penetrates
cells with compromised plasma membranes but will not cross
uncompromised cell membranes, was added at 5 m (ﬁnal) and
incubated (10 min) prior to automated reading of results by two-
channel ﬂuorescence microscopy (Cell Observer, Carl Zeiss, x5, ZEN
2012 software). Positive (pan-MHC I-speciﬁc mAb; IL-A88; [28])
and negative (FCS) controls were included with each serum-cell
combination, together with a complement control (no serum) and
live cell control (no serum and heat-inactivated complement). Total
cells (∼4000/sample) and dead cells were counted using a macro
in Image-J software [29].
To compare results from each cow, the serum dilution giving
80% cell killing was  estimated by interpolating between the serum
dilutions either side of 80%, assuming data followed a sigmoid
curve (Microsoft Excel, 2010). The cut-off of 80% was selected in
line with MHC  I typing assays employing CDC, where 80–100% is
classiﬁed as a strong positive [20,30]; 80% cell killing is also equiv-
alent to the reduction in PBMC seen in experimentally induced BNP
[6].
For each cow the percentage of positive reactions against the
panel of MHC  I-deﬁned lines was  determined (panel reactive anti-
body percentage; PRA) (see Fig. 2), as a means of estimating the
percentage of calves in the bovine population an individual cow’s
serum would be expected to react against.
2.5. Identiﬁcation of the MHC I alleles expressed on the MDBK cell
line and isolation of full-length gene products
Following isolation of RNA and synthesis of cDNA from MDBK
cells, a 375 bp fragment of the MHC  I heavy chains, includ-
ing exons 1 and 2 (which encode the polymorphic 1 and 2
domains), was ampliﬁed by PCR, using primers that amplify all
known classical bovine MHC  I alleles, as described previously
[31]. Following molecular cloning and sequencing, the sequences
were aligned using DNASIS MAX  (MiraiBio Group, Hitachi Solu-
tions America Ltd.), subjected to an NCBI BLAST search [32] and
sequence identities conﬁrmed by comparison with the bovine
MHC  I EBI database [33]. Full-length cDNAs were isolated using
consensus primers complementary to semi-conserved regions
at the 5′ end of the leader sequence and just beyond the 3′end of the cytoplasmic domain of the MHC  gene [31]. The PCR
products were cloned and sequenced, allowing identiﬁcation
of the full-length sequence for all but one identiﬁed MDBK-
MHC  I allele. For the remaining allele (BoLA 3*00402 variant),
3 ine 33 (2015) 3488–3496
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Fig. 1. Cows vaccinated with Pregsure have signiﬁcantly higher titres of functional
serum alloantibody against the MDBK-MHC I alleles and against bovine leukocytes.
Serum dilutions giving 80% cell killing against the ﬁve transfected P815 cells lines
expressing the MDBK-MHC I alleles (black bars) and a panel of twelve MHC  I deﬁned
bovine leukocyte cell lines (grey bars). Mean values +/− one standard deviation are
shown. T-tests, Genstat, ** p < 0.001, * p < 0.01, NS p > 0.05. The reactivity of serum
with the transfectants and leukocyte lines are not directly comparable due to differ-
ences in levels of MHC  I expression and susceptibility to complement lysis between490 C.R. Bell et al. / Vacc
lternative primers were designed based on database 3*00402
equence data (forward 5′-ACCATGGGGCCGCGAG-3′, reverse 5′-
CCTGAAGCCTGGATATAATTG-3′) and used to obtain a slightly
runcated version of the full-length allele (from 5′ leader sequence
o the middle of the cytoplasmic domain). The identity of the ﬁnal
roduct was conﬁrmed by sequencing.
.6. Production of transformed mouse cell lines expressing the
ndividual MDBK-MHC I alleles
Stably transfected P815 lines expressing the individual MDBK-
HC  I alleles were produced by transfection of the MHC  I heavy
hain alleles in pc-DNA-3.1/V5-his TOPO vectors into murine P815
ells by electroporation and culture in selective media (500 g/ml
418). Further selection of cells expressing the class I products
as conducted by indirect immunoﬂuorescence staining with the
ovine MHC  I-speciﬁc mAb  IL-A88 and polyclonal FITC-conjugated
oat anti-mouse IgG/A/M (Sigma-Aldrich) and single cell sorting
FACSAria III, BD Biosciences) allowing the production of clonal
ines. These were expanded and screened for expression by ﬂow
ytometery, with the highest expressing clones selected for subse-
uent work.
.7. Indirect immunoﬂuorescence staining for MHC  I expression
Cells were re-suspended at 2 × 107 cells/ml in either unsup-
lemented ﬁltered (0.2 m)  RPMI, for thrombocytes, or RPMI
upplemented with 2% FCS, 0.2% NaN3 for other cell types, and
tained by indirect immunoﬂuorescence with mAb  IL-A88 as
escribed above. For the washing steps, thrombocytes were cen-
rifuged at 1870 g for 10 min  and other cell types at 670 g for
 min. Cells were analysed by ﬂow cytometry, FACS Calibur or LSR
ortessa (BD Biosciences), and data analysed with FlowJo software
TreeStar Inc.). Where dead cell staining was required, 5 nm Sytox
ed (Life Technologies) was  added to the cells immediately prior to
nalysis.
. Results
.1. Identiﬁcation of MDBK-MHC I alleles
In order to identify the MHC  I alleles expressed by MDBK cells,
sed in production of virus for Pregsure vaccine, cloned PCR prod-
cts of MHC  I heavy chain were subjected to nucleotide sequencing.
ive distinct alleles were identiﬁed; 3*01101, 3*05001, 2*04801, a
ariant of 3*00402 (3*00402v) which differs from the EBI reference
equence by four amino acids, and a ﬁfth allele, as yet unnamed
accession number DQ1211179.1). The alleles 3*01101, 2*04801
nd 3*00402 comprise the recently published BF7 haplotype (26),
uggesting that the remaining alleles (3*05001 and DQ121179.1)
onstitute a novel haplotype. While the existence of additional
nidentiﬁed MHC  I alleles cannot be completely ruled out, sequenc-
ng of a large number of clones (n = 62) obtained using two  sets of
rimers suggests that this is unlikely.
.2. Cytotoxic activity of cow sera for the MDBK-MHC I alleles
To assess the cytotoxicity of cow sera for the MDBK-MHC I
lleles, cow sera were tested against transfected P815 cells express-
ng the individual MDBK-MHC I alleles using the CDC assay. After
ubtraction of background cytotoxicity against untransfected P815
ells, Pregsure-vaccinated dams were shown to have signiﬁcantly
igher titres of functional cytotoxic alloantibodies speciﬁc for
he MDBK-MHC I alleles than cows vaccinated with an alterna-
ive BVDV vaccine; however titres were not signiﬁcantly differentdifferent cell types, and variable sharing of MDBK target epitopes by the MHC I
alleles in the bovine lines (see Fig. 2).
between BNP-dams and Pregsure-vaccinated dams that had pro-
duced healthy calves (Fig. 1). The titres and speciﬁcities of the
alloantibodies for the different MDBK alleles were found to vary
between individual Pregsure vaccinated cows (Fig. 2).
3.3. Cytotoxicity of cow sera for a panel of MHC I-deﬁned bovine
leukocytes
In order to determine the functional activity of BNP-
alloantibody against bovine cells of diverse MHC  types, sera were
tested against a panel of 12 MHC  I-deﬁned bovine leukocyte cell
lines (Fig. S1) from Holstein cattle, using the CDC assay. In con-
trast to humans where each MHC  I haplotype expresses a ﬁxed
complement of three classical MHC  I genes, cattle show region con-
ﬁguration polymorphism in the MHC  with between one and three
genes expressed on any haplotype [34]. Thus these lines express
20 deﬁned bovine MHC  I alleles [26] and represent haplotypes
expressed by >94% of the Holstein cattle population [35]. Pregsure-
vaccinated cows were shown to have signiﬁcantly higher titres of
functional cytotoxic alloantibodies against the panel of cell lines
than unvaccinated cows or cows vaccinated with an alternative
BVDV vaccine. Pregsure-vaccinated cows which had produced a
BNP-affected calf had signiﬁcantly higher titres than those that had
produced a healthy calf (Fig. 1). Individual BNP-dams were found
to have cytotoxic alloantibodies of variable titres and speciﬁcities
against the different cell lines (Fig. 2). CDC assays using autologous
cell lines generated from four BNP-dams provided a negative con-
trol, with no serum achieving 80% cell killing, at any dilution tested
(serum at 1/5 dilution, mean cell killing 19.9% S.D. 8.4).
The mean PRA score, reﬂecting the number of cell lines recog-
nised by the sera, was  60% for BNP-cows and 39% for those non-BNP
Pregsure-cows giving a positive CDC result. There was  a signiﬁcant
relationship between mean alloantibody titres and PRA scores from
BNP-dams and Pregsure-cows (Fig. 3), with cows displaying allore-
activity against an increasing percentage of MHC  I genotypes as
their mean alloantibody titre increased.
Results from CDC assays performed using the MDBK-MHC I
mouse transfectants or bovine leukocytes could not be compared
directly due to differences in levels of MHC  I expression and sus-
ceptibility to complement lysis between different cell types, and
variable sharing of MDBK target epitopes by the MHC  I alleles in
the bovine lines (see Fig. 2). However, comparing the ranks of the
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ean alloantibody titres against the panel of bovine leukocyte lines
ith the P815-MDBK-MHC I transfectants showed a signiﬁcant
orrelation for BNP-dams (p < 0.05) and Pregsure-cows (p < 0.05)
Spearman’s Rank, Genstat, VSU International)inued).
3.4. Cytotoxicity of BNP-dam sera sequential parturitionsIn order to investigate whether pregnancy plays a role in the
induction of BNP-alloantibody and hence the speciﬁcity of the
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Fig. 3. Pregsure-vaccinated cows show alloreactivity against an increasing percent-
age of MHC  I genotypes as their mean alloantibody titre increases. Comparison
of  mean alloantibody titres and PRA scores from BNP-dams (n = 11) and Pregsure-
vaccinated animals (n = 8), by ﬁtting a non-linear regression model (sigmoid curve)
(Genstat, VSU International), showed a signiﬁcant relationship (p < 0.001). The BNP-
dam with the lowest PRA score and mean alloantibody titre produced a surviving
BNP case, while all other BNP-dams produced fatal BNP cases. Two Pregsure-
vaccinated cows had identical results (mean alloantibody titre 1, PRA score 0%) and
thus only 7 data points are visible. Closed circles ( ) Pregsure vaccinated dams that
produced healthy calves. Open circles (©) BNP-dams.
a
m
I
o
Fig. 5. Mononuclear leukocytes express MHC  I at a signiﬁcantly higher level than
thrombocytes and granulocytes. MHC  I expression levels, measured by median ﬂu-
orescence intensity (MFI) staining with IL-A88, on bovine peripheral blood cell
subtypes, MDBK cells and P815 cells. For peripheral blood cells, cell types were
gated on the basis of forward and side scatter characteristics, and mean values (+/−
one  standard deviation) are shown. T-tests, Genstat, ** p < 0.001,  p < 0.05. Compar-
cantly higher level (p < 0.001) than thrombocytes and granulocytes.
Secondly, to assess in vitro cytotoxicity of BNP-sera for periph-
eral blood cell types, CDC assays were performed on both whole
F
y
ontibodies, the cytotoxicity proﬁle of four BNP-dams was  deter-
ined at sequential parturitions, against the panel of MHC
-deﬁned cell lines. This revealed no apparent change in speciﬁcity
f the alloantibody (Fig. 4).
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ears  for 1 cow), sired by different bulls, against a panel of transformed bovine leukocyte
f  the Holstein population.  = 2011; = 2010;  = 2009.ison with MDBK cells revealed similar levels of MHC  I expression to that seen on
monocytes.
3.5. Variable BNP-alloantibody damage to haematopoietic cell
types
In order to investigate the hypothesis that the variation in BNP-
alloantibody damage to different haematopoietic cell types is due
to differences in the MHC  I expression levels by the cells, three sets
of experiments were performed. First, analyses of MHC  I expres-
sion levels on bovine peripheral blood cells (whole leukocytes
and thrombocytes) from three cows, by indirect immunoﬂuores-
cence staining for MHC  I and ﬂow cytometery, showed signiﬁcant
differences in MHC  I expression by different cell types (Fig. 5).
Mononuclear leukocytes were shown to express MHC  I at a signiﬁ-blood leukocyte and PBMC fractions obtained from three cows,
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ead  cell populations of bovine bone marrow following BNP-serum-induced compl
 BNP-dams. Black line (—) dead cells, grey line ( ) live cells, dotted line (. . .)  pe
sing sera from three BNP-dams. Signiﬁcantly greater cytotoxic-
ty (p < 0.001) was seen for PBMC than for whole leucocytes (mean
erum dilution giving 80% cell killing 1/502 for PBMC and 1/161 for
eukocytes). Examination of leukocytes that survived the CDC assay
y light microscopy conﬁrmed selective killing of mononuclear
ells and relative sparing of granulocytes (Fig. S2).
Thirdly, to investigate the MHC  I expression levels of bone
arrow cells that survived BNP-serum-induced complement-
ependent lysis, unstained bone marrow cells were subjected to
 CDC assay, followed by staining for MHC  I expression, vital stain-
ng (Sytox Red), and ﬂow cytometery. Analysis of the live and dead
ell populations obtained showed that live cells had consistently
ower MHC  I expression, and killed cells consistently higher MHC
 expression, compared to the control sample which had not been
ncubated with BNP-sera (Fig. 6). Furthermore, the percentage of
ead cells and their increase in MHC  I expression were signiﬁcantly
orrelated (p < 0.001, Spearman’s Rank, Genstat).
. Discussion
The establishment of a reproducible semi-automated
omplement-dependent cytotoxicity assay for the assessment
f cow sera allowed sensitive functional quantiﬁcation of the
peciﬁcity of BNP alloantibody. Five expressed classical MHC
 alleles were identiﬁed in the MDBK cell line, and generation
f stably transfected mouse cell lines expressing these alleles
llowed assessment of the speciﬁc alloreactivity of cow sera for the
ndividual alleles. The results demonstrated that cows vaccinated
ith Pregsure have signiﬁcantly higher titres of functional MHC
-speciﬁc alloantibodies than unvaccinated cows or cows vacci-
ated with an alternative BVDV vaccine. All BNP-dams and 50%
f Pregsure-cows tested were shown to have a variable proﬁle of
peciﬁcity for individual MDBK-MHC I alleles, with different cows
xhibiting cytotoxicity for different alleles.
Pregsure vaccinated cows with higher alloantibody titres
gainst the MDBK-MHC I alleles also had higher alloantibody titres
gainst a panel of bovine leukocyte cell lines. This ﬁnding indicatession than cells that are spared. MHC  I expression, by ﬂow cytometry, of live and
t-mediated lysis (ILA-88+ FITC-conjugated secondary and Sytox Red). Results from
age dead cells.
that a dominant alloantibody target on MDBK cells is shared by the
leukocyte lines and, coupled with the evidence of strong reactiv-
ity with the MDBK MHC  I alleles, suggests that MHC I is a major
antigen. Given that none of the individual MHC I alleles identiﬁed
from the MDBK cell line was present in the panel of bovine leuko-
cyte cell lines assessed, this implies that the alloantibody measured
in these experiments is cross-reactive with a number of bovine
MHC  I alleles. This is consistent with the nature of MHC  I sequence
polymorphism, where short stretches of amino acid sequence are
frequently shared by different alleles. Studies of mouse monoclonal
antibodies have also shown that antibodies generated against MHC
I proteins expressed by a particular animal recognise a range of epi-
topes, which show variable cross-reactivity with other MHC  I alleles
[36]. Thus, it would be expected that individual Pregsure vaccinated
cows produce a unique proﬁle of MHC  I-speciﬁc alloantibodies,
reﬂecting the epitopes on their own  MHC  I alleles that differ from
those on MDBK cells. The alloantibodies would then show vary-
ing degrees of cross-reactivity with the MHC  I alleles expressed on
other haplotypes. This variation, coupled with the number of these
antibody speciﬁcities that are expressed by the paternal haplotype
of the calf would then determine the risk of developing BNP.
Approximately 94% of Holstein cattle express at least one of
the MHC  I haplotypes examined in the current study [35]. Hence,
based on the proportion of cell lines in the test panel that were
recognised by alloantibody from individual BNP-dams, on average
the sera would be expected to react with approximately 60% of
calves in the Holstein cattle population, a ﬁgure that is consistent
with the proportions of calves that show clinical signs of BNP in
colostrum feeding experiments [5]. However, Pregsure-vaccinated
cows that did not produce a BNP-calf, but had signiﬁcant titres of
alloantibody, would have a reduced likelihood of producing a BNP
calf since they react with a lower proportion of calf MHC  types
as a consequence of less cross-reactive alloantibody. Thus, among
Pregsure-vaccinated cows there is a continuum both of alloanti-
body titre and cross-reactivity of the alloantibody with other MHC
I alleles, with those cows with higher alloantibody titres showing
greater cross reactivity and producing clinically affected calves.
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his ﬁnding is also consistent with the identiﬁcation of milder
ubclinical forms of BNP. Those Pregsure vaccinated cows which
roduced alloantibody (50%) had an average PRA score of 29%, indi-
ating an expected incidence of subclinical disease in calves of 15%.
his is consistent with our recent ﬁnding that approximately 15%
f calves born in a Pregsure-vaccinated herd exhibited abnormal
aematological values [37].
Levels of MHC  I expression on bovine leukocyte subtypes
nd thrombocytes were shown to correlate with the extent to
hich these cell types are damaged by BNP-alloantibody both in
n vitro and in vivo [6], with cells with higher MHC  I expression
evels (mononuclear leukocytes) being most susceptible to BNP-
lloantibody damage. Complement-dependent killing of bovine
one marrow cells by BNP-serum was demonstrated in vitro, and
ells surviving killing were shown to have a consistently lower
evels of MHC  I expression than killed cells. This provides fur-
her supporting evidence for the dominant role of MHC  I-speciﬁc
lloantibodies in the pathogenesis of BNP and indicates that the
evel of cell surface expression is a key factor in determining
he selectivity of cell destruction. These ﬁndings, coupled with
he complement-ﬁxing isotype of BNP-alloantibody [38] and the
inetic similarities between lymphocyte depletion in BNP-calves
nd depletion using complement-ﬁxing monocloncal antibodies
39], are consistent with a role for complement-mediated lysis in
NP pathogenesis. However further work would be required to
onﬁrm this.
Sera obtained from BNP dams at sequential parturitions showed
 remarkably consistent proﬁle of alloantibody speciﬁcities. An
lteration in BNP-dam alloantibody speciﬁcity might be expected at
ubsequent parturitions, if BNP-alloantibody was  being stimulated
y exposure to foetal MHC  I alleles, as naturally occurring alloanti-
ody has broader speciﬁcity in multiparous than primiparous cows,
16]. As this is not the case, it appears the foetus does not directly
nﬂuence the speciﬁcity of BNP-alloantibody. However, this ﬁnding
oes not preclude the possibility of the foetal calf boosting titres of
re-existing MDBK-induced speciﬁcities.
. Conclusion
The results of this study provide evidence that MHC  I-speciﬁc
lloantibodies play a dominant role in the pathogenesis of BNP.
trong reactivity of BNP sera with the MHC  I alleles expressed by
DBK cells was demonstrated. The antibody-mediated destruction
f blood and bone marrow cells, measured in vitro by complement-
ediated lysis, was shown to be dependent on the titre and
peciﬁcity of alloantibody produced by individual cows and the
ensity of surface MHC  I expression by different cell types. Col-
ectively, the results support the hypothesis that MHC  I molecules
riginating from MDBK cells used in production of Pregsure, cou-
led with the use of a powerful adjuvant, are responsible for the
eneration of pathogenic alloantibodies.
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